208 related articles for article (PubMed ID: 25553434)
1. Recent trends of chalcones potentialities as antiproliferative and antiresistance agents.
Winter E; Locatelli C; Di Pietro A; Creczynski-Pasa TB
Anticancer Agents Med Chem; 2015; 15(5):592-604. PubMed ID: 25553434
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of novel α-substituted chalcones with potent anti-cancer activities and ability to overcome multidrug resistance.
Riaz S; Iqbal M; Ullah R; Zahra R; Chotana GA; Faisal A; Saleem RSZ
Bioorg Chem; 2019 Jun; 87():123-135. PubMed ID: 30884306
[TBL] [Abstract][Full Text] [Related]
3. A Review on Mechanisms of Anti Tumor Activity of Chalcones.
Sharma R; Kumar R; Kodwani R; Kapoor S; Khare A; Bansal R; Khurana S; Singh S; Thomas J; Roy B; Phartyal R; Saluja S; Kumar S
Anticancer Agents Med Chem; 2015; 16(2):200-11. PubMed ID: 25980813
[TBL] [Abstract][Full Text] [Related]
4. MDR-reversal activity of chalcones.
Ivanova A; Batovska D; Engi H; Parushev S; Ocsovszki I; Kostova I; Molnar J
In Vivo; 2008; 22(3):379-84. PubMed ID: 18610751
[TBL] [Abstract][Full Text] [Related]
5. "Discovery and development of new anticancer drugs inspired from natural product leads" part 1.
Rane R; Karpoormath R
Anticancer Agents Med Chem; 2015; 15(5):536. PubMed ID: 25981059
[No Abstract] [Full Text] [Related]
6. Anticancer Activity of Polyether Ionophore-Salinomycin.
Antoszczak M; Huczyński A
Anticancer Agents Med Chem; 2015; 15(5):575-91. PubMed ID: 25553435
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity and modes of action of 4'-hydroxy-2',6'-dimethoxychalcone and other flavonoids toward drug-sensitive and multidrug-resistant cancer cell lines.
Kuete V; Nkuete AH; Mbaveng AT; Wiench B; Wabo HK; Tane P; Efferth T
Phytomedicine; 2014 Oct; 21(12):1651-7. PubMed ID: 25442273
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of three naturally occurring flavonoid derived compounds (artocarpesin, cycloartocarpesin and isobavachalcone) towards multi-factorial drug-resistant cancer cells.
Kuete V; Mbaveng AT; Zeino M; Fozing CD; Ngameni B; Kapche GD; Ngadjui BT; Efferth T
Phytomedicine; 2015 Nov; 22(12):1096-102. PubMed ID: 26547532
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory and antiproliferative prenylated chalcones from Hedysarum gmelinii.
Liu Y; Zhang J; Wen R; Tu GZ; Chen HB; Liang H; Zhao YY
J Asian Nat Prod Res; 2018 Nov; 20(11):1009-1018. PubMed ID: 29589472
[TBL] [Abstract][Full Text] [Related]
10. Four new chalcones from Erythrina abyssinica.
Cui L; Thuong PT; Lee HS; Njamen D; Mbafor JT; Fomum ZT; Lee J; Kim YH; Oh WK
Planta Med; 2008 Mar; 74(4):422-6. PubMed ID: 18484536
[TBL] [Abstract][Full Text] [Related]
11. Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins.
Mai CW; Yaeghoobi M; Abd-Rahman N; Kang YB; Pichika MR
Eur J Med Chem; 2014 Apr; 77():378-87. PubMed ID: 24675137
[TBL] [Abstract][Full Text] [Related]
12. Symmetric bis-chalcones as a new type of breast cancer resistance protein inhibitors with a mechanism different from that of chromones.
Winter E; Devantier Neuenfeldt P; Chiaradia-Delatorre LD; Gauthier C; Yunes RA; Nunes RJ; Creczynski-Pasa TB; Di Pietro A
J Med Chem; 2014 Apr; 57(7):2930-41. PubMed ID: 24611893
[TBL] [Abstract][Full Text] [Related]
13. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.
Lorendeau D; Dury L; Genoux-Bastide E; Lecerf-Schmidt F; Simões-Pires C; Carrupt PA; Terreux R; Magnard S; Di Pietro A; Boumendjel A; Baubichon-Cortay H
Biochem Pharmacol; 2014 Aug; 90(3):235-45. PubMed ID: 24875445
[TBL] [Abstract][Full Text] [Related]
14. Chalcone Scaffolds as Anticancer Drugs: A Review on Molecular Insight in Action of Mechanisms and Anticancer Properties.
Shukla S; Sood AK; Goyal K; Singh A; Sharma V; Guliya N; Gulati S; Kumar S
Anticancer Agents Med Chem; 2021; 21(13):1650-1670. PubMed ID: 33238850
[TBL] [Abstract][Full Text] [Related]
15. Advances in chalcones with anticancer activities.
Karthikeyan C; Moorthy NS; Ramasamy S; Vanam U; Manivannan E; Karunagaran D; Trivedi P
Recent Pat Anticancer Drug Discov; 2015; 10(1):97-115. PubMed ID: 25138130
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms underlying chemopreventive potential of butein: Current trends and future perspectives.
Tuli HS; Joshi R; Aggarwal D; Kaur G; Kaur J; Kumar M; Parashar NC; Khan MA; Sak K
Chem Biol Interact; 2021 Dec; 350():109699. PubMed ID: 34648814
[TBL] [Abstract][Full Text] [Related]
17. Chalcone Derivatives and their Activities against Drug-resistant Cancers: An Overview.
Xiao J; Gao M; Diao Q; Gao F
Curr Top Med Chem; 2021; 21(5):348-362. PubMed ID: 33092509
[TBL] [Abstract][Full Text] [Related]
18. Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.
Joshi P; Vishwakarma RA; Bharate SB
Eur J Med Chem; 2017 Sep; 138():273-292. PubMed ID: 28675836
[TBL] [Abstract][Full Text] [Related]
19. Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology.
Menezes JCJMDS; Diederich MF
Eur J Med Chem; 2019 Nov; 182():111637. PubMed ID: 31494471
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis and Docking Studies of Flavokawain B Type Chalcones and Their Cytotoxic Effects on MCF-7 and MDA-MB-231 Cell Lines.
Abu Bakar A; Akhtar MN; Mohd Ali N; Yeap SK; Quah CK; Loh WS; Alitheen NB; Zareen S; Ul-Haq Z; Shah SAA
Molecules; 2018 Mar; 23(3):. PubMed ID: 29518053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
